Related references
Note: Only part of the references are listed.Immunotherapy for glioblastoma: the promise of combination strategies
Mathilde Bausart et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma
A-Reum Kim et al.
ONCOIMMUNOLOGY (2022)
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng et al.
FRONTIERS IN ONCOLOGY (2022)
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Vidhya M. Ravi et al.
CANCER CELL (2022)
The emerging landscape of spatial profiling technologies
Jeffrey R. Moffitt et al.
NATURE REVIEWS GENETICS (2022)
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models
Gilles Berger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Revisiting the HIF switch in the tumor and its immune microenvironment
Sophie J. Cowman et al.
TRENDS IN CANCER (2022)
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak et al.
CLINICAL CANCER RESEARCH (2021)
Immune checkpoint inhibitors in GBM
Eudocia Q. Lee
JOURNAL OF NEURO-ONCOLOGY (2021)
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective
Paola Allavena et al.
CLINICAL CANCER RESEARCH (2021)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies
Aleksandr Sokolov et al.
PHARMACOLOGICAL REVIEWS (2021)
Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology
Aline P. Becker et al.
CANCERS (2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso et al.
CELL (2021)
Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Benjamin T. Himes et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases
Panagiotis F. Christopoulos et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunotherapy for Glioblastoma: Current Progress and Challenge
Miranda W. Yu et al.
FRONTIERS IN IMMUNOLOGY (2021)
TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
Itay Raphael et al.
FRONTIERS IN IMMUNOLOGY (2021)
The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin
Gong Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells
Hong Liu et al.
PLOS ONE (2021)
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
Luke Maggs et al.
FRONTIERS IN NEUROSCIENCE (2021)
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma
Apeng Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
Hila Shaim et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions
Kelly Mitchell et al.
NEURO-ONCOLOGY (2021)
Glioma stem cells and their roles within the hypoxic tumor microenvironment
Nathaniel H. Boyd et al.
THERANOSTICS (2021)
Insights in the immunobiology of glioblastoma
Dimitrios Strepkos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H. J. Close et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy
Aleksandra Ellert-Miklaszewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Ana Rita Pombo Antunes et al.
ELIFE (2020)
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance
Leila Akkari et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Charles P. Couturier et al.
NATURE COMMUNICATIONS (2020)
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
Joshua R. D. Pearson et al.
FRONTIERS IN IMMUNOLOGY (2020)
Glioblastoma Stem cells: Driving Resilience through Chaos
Briana C. Prager et al.
TRENDS IN CANCER (2020)
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William Tomaszewski et al.
CLINICAL CANCER RESEARCH (2019)
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments
Sally L. Perrin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2019)
The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme
Sara Ramezani et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor
Zhi-liang Wang et al.
ONCOIMMUNOLOGY (2019)
Glioblastoma: Microenvironment and Niche Concept
Davide Schiffer et al.
CANCERS (2019)
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan et al.
NEURO-ONCOLOGY (2018)
The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma
Diana A. Aderetti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (vol 32, pg 42, 2017)
Qianghu Wang et al.
CANCER CELL (2018)
Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma
Suvi Luoto et al.
CANCER RESEARCH (2018)
Immunotherapy of Primary Brain Tumors: Facts and Hopes
Robin A. Buerki et al.
CLINICAL CANCER RESEARCH (2018)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2 based antagonists for cancer therapy
Gal Yosef et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar
Vashendriya V. V. Hira et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2018)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Temozolomide for immunomodulation in the treatment of glioblastoma
Aida Karachi et al.
NEURO-ONCOLOGY (2018)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
Amber J. Giles et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Human glioblastoma arises from subventricular zone cells with low-level driver mutations
Joo Ho Lee et al.
NATURE (2018)
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
Mohammed Diksin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The vascular basement membrane in the healthy and pathological brain
Maj S. Thomsen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomase
Gary Kohanbash et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Overcoming therapeutic resistance in glioblastoma: the way forward
Satoru Osuka et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
Hua-fu Zhao et al.
MOLECULAR CANCER (2017)
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Nicole Colwell et al.
NEURO-ONCOLOGY (2017)
Correlation of immune phenotype with IDH mutation in diffuse glioma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2017)
PAF promotes stemness and radioresistance of glioma stem cells
Derrick Sek Tong Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database
Isabella Gomes Cantanhede et al.
SCIENTIFIC REPORTS (2017)
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
Nichola Cruickshanks et al.
CANCERS (2017)
Vascular regulation of glioma stem-like cells: a balancing act
Lucy J. Brooks et al.
CURRENT OPINION IN NEUROBIOLOGY (2017)
Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy
Wenchao Zhou et al.
CELL STEM CELL (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Alexander Scholz et al.
EMBO MOLECULAR MEDICINE (2016)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Astrocytes promote glioma invasion via the gap junction protein connexin43
W. C. Sin et al.
ONCOGENE (2016)
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
Baoli Hu et al.
CELL (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
C. Depner et al.
NATURE COMMUNICATIONS (2016)
EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
Benjamin Krusche et al.
ELIFE (2016)
Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
Alessia Fidoamore et al.
STEM CELLS INTERNATIONAL (2016)
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Konrad Gabrusiewicz et al.
JCI INSIGHT (2016)
Increased proportion of FoxP3+regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
Elias J. Sayour et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2015)
The role of galectin-3 and galectin-3-binding protein in venous thrombosis
Elise P. DeRoo et al.
BLOOD (2015)
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma
Katharina Seystahl et al.
NEURO-ONCOLOGY (2015)
Neoplastic cells are a rare component in human glioblastoma microvasculature
Fausto J. Rodriguez et al.
Oncotarget (2015)
Glioblastoma: Defining Tumor Niches
Dolores Hambardzumyan et al.
TRENDS IN CANCER (2015)
Neutrophils Promote the Malignant Glioma Phenotype through S100A4
Ji Liang et al.
CLINICAL CANCER RESEARCH (2014)
Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages
Anna Carolina Carvalho da Fonseca et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Susobhan Sarkar et al.
NATURE NEUROSCIENCE (2014)
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells
Stacey Watkins et al.
NATURE COMMUNICATIONS (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
W. Caleb Rutledge et al.
CLINICAL CANCER RESEARCH (2013)
A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells
Marika A. Russo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Expansion of CD 133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy Laboratory investigation
Kaoru Tamura et al.
JOURNAL OF NEUROSURGERY (2013)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
A Galectin-3-Dependent Pathway Upregulates Interleukin-6 in the Microenvironment of Human Neuroblastoma
Ayaka M. Silverman et al.
CANCER RESEARCH (2012)
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
Liuqi Yang et al.
EXPERIMENTAL CELL RESEARCH (2012)
Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development
Gary Kohanbash et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Microglial Stimulation of Glioblastoma Invasion Involves Epidermal Growth Factor Receptor (EGFR) and Colony Stimulating Factor 1 Receptor (CSF-1R) Signaling
Salvatore J. Coniglio et al.
MOLECULAR MEDICINE (2012)
Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
Chun Geun Lee et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2011)
Effect of Brain- and Tumor-Derived Connective Tissue Growth Factor on Glioma Invasion
Lincoln A. Edwards et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression
Samuel Beck et al.
MOLECULES AND CELLS (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Transdifferentiation of glioblastoma cells into vascular endothelial cells
Yasushi Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
Marzia B. Gariboldi et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
Sascha Seidel et al.
BRAIN (2010)
The perivascular niche microenvironment in brain tumor progression
Nikki Charles et al.
CELL CYCLE (2010)
Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
Sung-Suk Chae et al.
CLINICAL CANCER RESEARCH (2010)
The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion
Mitsutoshi Nakada et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Accumulation of CD 133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation Clinical article
Kaoru Tamura et al.
JOURNAL OF NEUROSURGERY (2010)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
Glioblastoma stem-like cells give rise to tumour endothelium
Rong Wang et al.
NATURE (2010)
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
John F. de Groot et al.
NEURO-ONCOLOGY (2010)
Experimental approaches for the treatment of malignant gliomas
Leopold Arko et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Francesca Pistollato et al.
STEM CELLS (2010)
Galectin 3 Induces a Distinctive Pattern of Cytokine and Chemokine Production in Rheumatoid Synovial Fibroblasts via Selective Signaling Pathways
Andrew Filer et al.
ARTHRITIS AND RHEUMATISM (2009)
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
O. Martinho et al.
BRITISH JOURNAL OF CANCER (2009)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
Agda K. Lucio-Eterovic et al.
CLINICAL CANCER RESEARCH (2009)
The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice
Ravesanker Ezhilarasan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment
Emmanuelle di Tomaso et al.
PLOS ONE (2009)
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion
D. S. Markovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells
Suvobroto Nandi et al.
CANCER RESEARCH (2008)
Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM
Rose Du et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1α levels in gliomas
O-H Lee et al.
ONCOGENE (2008)
Microglia-derived TGF-β as an important regulator of glioblastoma invasion -: an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor
A. Wesolowska et al.
ONCOGENE (2008)
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo
Ta-Jen Liu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model
Seung-Hee Kang et al.
CANCER RESEARCH (2006)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion
David Zagzag et al.
LABORATORY INVESTIGATION (2006)
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Serena Pellegatta et al.
CANCER RESEARCH (2006)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation
Victor A. Levin et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis
R Erber et al.
EMBO JOURNAL (2006)
'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Yuan Rong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2
DS Markovic et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
B Kaur et al.
NEURO-ONCOLOGY (2005)
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification
GJ Guillemin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis
SS Lakka et al.
ONCOGENE (2004)
Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39
F Fusetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IS201, a specific alpha v beta 3 integrin inhibitor, reduces glioma growth in vivo
L Bello et al.
NEUROSURGERY (2003)
αvβ3 and αvβ5 integrin expression in glioma periphery
L Bello et al.
NEUROSURGERY (2001)
Share Paper
